Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institutul De Medicina Si FarmaciefiledCriticalInstitutul De Medicina Si Farmacie
Priority to RO130922ApriorityCriticalpatent/RO100217B1/ro
Publication of RO100217A2publicationCriticalpatent/RO100217A2/ro
Publication of RO100217B1publicationCriticalpatent/RO100217B1/ro
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
Preparatul vaginal, conform inventiei, este constituit din 625000 UI Estradiol, 150000 UI vitamina A, 125000 UI vitamina E, 10 parti tinctura de galbenele, 30 parti glicerina, 10 parti hidrolizat de colagen cu greutate moleculara 20000, 80 parti solutie conservanta nipagin : nipasol, 10 parti lactat de magneziu, 190 parti glicerina, 10 parti lecitina din soia, cu sau fara 5 parti pantotenat de calciu, partile fiind exprimate în greutate.
RO130922A1987-12-141987-12-14Preparat vaginal sub forma de ovule
RO100217B1
(ro)
D-homoandrostane-17alpha-carboxylic acids,derivatives thereof and 17alpha-spiroethers,their manufacture and pharmaceutical compositions containing them
Procedimiento para la obtencion de y-lactonas de acidos 6 beta, 17-dihidroxi-7 alfa-(alcoxi inferior) -carbonil-3-oxo-17 alfa'pregn-4-eno-21-carboxilicos.